SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Martin Luther — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMartin Luther
Date of birth1483-11-19
IdentifiersMRN HR-RE004-SYN-TD; SSN (made up) 000-04-3892
Document date1527-08-11
AuthorOttilie Brandt-Mensah, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-week review of vertigo attacks and low mood, seen the same day in otology. [S]

History of Present Illness

Professor Luther returns two weeks after his first visit, on the day of his consultation with Dr. Okafor-Lindqvist. He has kept the attack diary. He had one attack six days ago that began with roaring and fullness in the left ear, then spinning for about three hours with nausea; he lay down, took one meclizine and slept, and the roaring settled back to its usual level by the next morning. No headache, light sensitivity or visual aura came with it. He has had dull headaches on two other days, without dizziness. His mood is still low; he is sleeping five or six hours, feels guilty and joyless, and has had to push himself to write and teach. He has had no thoughts of death or of harming himself. He has never had a period of days with little need for sleep, racing thoughts or unusual energy. [S]

ElementDetail
AttacksOne since intake, three hours, with left-ear roaring and fullness
MeclizineOne dose
HeadacheTwo dull headaches without dizziness; none with the attack
MoodLow, guilty, joyless; poor sleep; no thoughts of self-harm
Mania screenNo past hypomanic or manic episodes

Review of Systems

SystemResultFinding
Ears, nose, mouth, and throatPositiveConstant left-ear tinnitus and fullness; muffled hearing on the left
NeurologicalPositiveOne vertigo attack; two dull headaches; no weakness, numbness, double vision or slurred speech
GastrointestinalPositiveNausea during the attack; bowels regular
GenitourinaryNegativeNo flank pain or blood in the urine
PsychiatricPositiveLow mood, guilt, loss of interest, broken sleep; no suicidal ideation

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Meclizine 25 mg tablet, one by mouth up to every 8 hours during a severe vertigo attack only, for no more than 3 days at a timeevery 8 hours as needed during a severe attack, at most 3 days at a timeOral route1527-07-28activeS
Hydrochlorothiazide 25 mg tablet, one by mouth each morningonce daily in the morningOral route1527-08-11activeS
Sertraline 25 mg tablet, one by mouth each morning for one weekonce daily in the morningOral route1527-08-11 to 1527-08-18completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1527-08-11Body height175cmS
1527-08-11Body weight86.2kgS
1527-08-11Body mass index (BMI) [Ratio]28.1kg/m2S
1527-08-11Systolic blood pressure126mm[Hg]S
1527-08-11Diastolic blood pressure80mm[Hg]S
1527-08-11Heart rate74/minS
1527-08-11Respiratory rate14/minS
1527-08-11Body temperature36.6CelS
1527-08-11Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1527-08-11Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]14{score}S

Physical Exam

Vital signs recorded on 1527-08-11; see the Vital Signs section. [S]

SystemFinding
GeneralWell-built man; blood pressure 126/80, pulse 74; weight 86.2 kg
EarsEar canals and tympanic membranes normal; Weber lateralizes to the right; Rinne positive on both sides
NeurologicalNo spontaneous or gaze-evoked nystagmus; head impulse test normal; cranial nerves, coordination and gait normal; Romberg steady
PsychiatricMood low, affect constricted; speech fluent and forceful; no suicidal ideation; no psychotic features

Problems

ProblemClinical statusVerificationCodeProvenance
Recurrent attacks of spinning vertigo for about three months, the worst twelve days ago, lasting hours, with roaring tinnitus, fullness and muffled hearing in the left ear and nausea, the tinnitus persisting between attacks; with low mood, poor sleep and loss of interest; cause not established at intake: an inner-ear disorder suspected, with vestibular migraine, vestibular schwannoma and posterior circulation stroke to be excluded and depression to be assessed; otology consultation requestedresolvedconfirmed R42S — Synthetic presenting problem anchored to his documented attacks of April and July 1527; superseded by the diagnoses at the second visit.
Ménière disease of the left ear, definite (AAO-HNS 1521 and Bárány Society criteria), with low-frequency sensorineural hearing loss and persistent tinnitus in the left ear; vestibular migraine considered and judged unlikely as the main cause; vestibular schwannoma excluded by MRIactiveconfirmed H81.02S — Synthetic modern diagnosis made at the otology consultation, linked to his documented attacks and to the retrospective diagnosis of Ménière disease (R).
Major depressive disorder, recurrent, moderate (DSM-5-TR), with low mood, poor sleep, loss of interest, guilt and fatigue for about two months, after earlier periods of spiritual crisis and low mood; no suicidal ideationactiveconfirmed F33.1S — Synthetic modern diagnosis linked to his documented Anfechtungen and low periods; not a claim that he was so diagnosed; the retrospective psychiatric readings are disputed (R).
Urinary stone disease: one stone passed spontaneously last year after severe pain; stone type and metabolic risk not yet known at intakeactiveconfirmed Z87.442S — Synthetic modern problem anchored to his documented first stone in 1526.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyVertigo attack diary: number, duration, hearing, tinnitus, fullness, headacheEvery visitCompleted todayOne three-hour attack since intake; two headaches without vertigo; Dizziness Handicap Inventory 52 (moderate) (Dizziness Handicap Inventory in the notes; no LOINC code used)
ExaminationAudiometry (pure-tone and speech) with tympanometryAt diagnosis; repeat at about three months and with any change in hearingCompleted todayLeft low-frequency sensorineural loss of 40 dB at 250 and 500 Hz; word recognition 88 percent left, 100 percent right; normal tympanograms
ImagingMRI of the internal auditory canals with gadoliniumOnce, to exclude a retrocochlear lesion with asymmetric hearing lossOrderedOrdered today
ExaminationVestibular function testing and electrocochleographyNot routinely for diagnosisNot indicatedThe guideline advises against routine testing to diagnose Ménière disease; the history and audiogram are enough
Medication safetyVestibular suppressant useEvery visitCompleted todayOne meclizine dose in two weeks; limited to severe attacks
Self-managementSodium, caffeine and alcohol limitsEvery visitOrderedEducation given today
ReferralOtology consultationOnce, at diagnosisCompleted todaySeen by Dr. Okafor-Lindqvist today
SurveyPHQ-9At least monthly during acute treatmentCompleted today14, from 15 at intake
SurveyMood Disorder Questionnaire at the initial depression workupOnce at the initial workup; repeat if hypomanic features emergeCompleted todayNegative; no past hypomania or mania
SurveySuicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9)Every visitCompleted todayNo suicidal ideation, intent or plan; PHQ-9 item 9 scored 0. Safety plan reviewed
Medication safetySSRI tolerability check two weeks after starting2 weeks after starting and after each dose changeOrderedDue in two weeks; with the sodium check on the thiazide
LaboratorySodium, potassium, creatinine and calcium on a thiazide with an SSRITwo to four weeks after starting, then every three to six monthsOrderedSodium and potassium in two to four weeks

Goal progress:

Guideline basis: Clinical Practice Guideline: Ménière's Disease (2020); Diagnostic criteria for Menière's disease (2015); Vestibular migraine: diagnostic criteria (update) (2022); Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial) (2016); Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)

Follow-up: Blood test in two to four weeks. Review in six weeks. Next scheduled visit 1527-09-08: periodic adult preventive visit. [S]